Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Receives Cannabis Sales License from Health Canada

October 1, 2021


FOR IMMEDIATE RELEASE RDT branded QuickSips™ and QuickStrip™ will be available in stores from coast-to-coast BURLINGTON, Ontario – October 1, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced the successful receipt...

Rapid Dose Therapeutics Welcomed Premier Doug Ford to Tour Burlington Facility

September 28, 2021


Productive discussion regarding “made-in-Ontario COVID-19 vaccine candidate” BURLINGTON, Ontario – September 28, 2021- Yesterday afternoon, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) welcomed Premier Doug Ford and Caucus member Stephen Crawford MPP, to their head office and manufacturing facility in Burlington, Ontario...

Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones

September 15, 2021


Pre-clinical testing has demonstrated manufacturing stability and statistically significant antibody production BURLINGTON, Ontario – September 15, 2021- Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are reporting a preliminary, yet significant milestone in the investigation of an orally...

Rapid Dose Therapeutics Reports Q1 Financial Results and Exercise of Warrant for Net Proceeds of $689,000

August 26, 2021


FOR IMMEDIATE RELEASE BURLINGTON, Ontario – August 25, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), today reported its Q1 financial results. “The Company is on a path of transformation and is well-positioned to drive innovation and our business plan forward as...

Rapid Dose Therapeutics Reports Fiscal Year 2021 Financial Results

August 26, 2021


FOR IMMEDIATE RELEASE BURLINGTON, Ontario – August 25, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the“Company”) (CSE: DOSE), today reported its financial results for the year ended February 28, 2021. “The Company achieved a number of key milestones this year, is transitioning efficiently into its...

Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order

August 10, 2021


TORONTO, ONTARIO, August 10, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) is providing a bi-weekly update on the status of the management cease trade order granted on  June 29, 2021 (the “MCTO”) by its principal regulator, the Ontario Securities Commission, in accordance...

RAPID DOSE THERAPEUTICS ANNOUNCES GRANT OF INCENTIVE STOCK OPTIONS

July 30, 2021


BURLINGTON, Ontario July 30, 2021 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), announces, pursuant to its Stock Option Plan, the granting of incentive stock options to purchase 2,100,000 common shares at an exercise price of $0.65 per share. Each has a...

Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order

July 27, 2021


TORONTO, ONTARIO, July 27, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) is providing a bi-weekly update on the status of the management cease trade order granted on  June 29, 2021 (the “MCTO”) by its principal regulator, the Ontario Securities Commission, in accordance...

Rapid Dose Therapeutics Announces the Appointment of Advisory Board

July 22, 2021


Rapid Dose Therapeutics Announces the Appointment of Advisory Board Ron Brooks, CPA, CA, ICD.D, Nick DiRenzo, FCA, FCPA, ICD.D and Anne Lachance, ICD.D appointed to help support the Company’s global expansion BURLINGTON, Ontario – July 22, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”)...

Rapid Dose Therapeutics and McMaster University Provide Update on COVID-19 Vaccine Research Collaboration with Orally Dissolvable QuickStrip™ Technology

July 20, 2021


Rapid Dose Therapeutics and McMaster University Enter Next Stage of COVID-19 QuickStrip™ Vaccine Research Ahead of Schedule Pre-clinical in vivo testing expected to prove efficacy of QuickStrip technology in the delivery of vaccines   BURLINGTON, Ontario – July 20, 2021- Rapid Dose Therapeutics Corp. (“RDT”...

1 2 3 4 5 6 7 8